Improved explant method to isolate umbilical cord-derived mesenchymal stem cells and their immunosuppressive properties

Tissue Engineering - Part C: Methods

Volumn 21, Issue 4, 2015, Pages 367-372

  Mori, Yuka ^a   Ohshimo, Jun ^b   Shimazu, Takahisa ^a   He, Haiping ^a,c   Takahashi, Atsuko ^a   Yamamoto, Yuki ^a   Tsunoda, Hajime ^d   Tojo, Arinobu ^a,c   Nagamura Inoue, Tokiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Tsubakimoto Chain Co   (Japan)

^c THE UNIVERSITY OF TOKYO   (Japan)

^d Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CYTOLOGY; FLOWCHARTING; MOLECULAR BIOLOGY; STAINLESS STEEL; STEM CELLS; TISSUE; TISSUE ENGINEERING;

CELL RECOVERY RATES; CONVENTIONAL METHODS; DENDRITIC CELLS; INCUBATION TIME; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; STAINLESS STEEL MESH; UMBILICAL CORDS;

CELL CULTURE;

5' NUCLEOTIDASE; CD45 ANTIGEN; ENDOGLIN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; THY 1 ANTIGEN; DIFFERENTIATION ANTIGEN;

ADHERENT CELL; ADIPOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL SELECTION; CHONDROGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; EXPLANT; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL; STAINLESS STEEL IMPLANT; STAINLESS STEEL MESH; UMBILICAL CORD; UMBILICAL CORD BLOOD DERIVED MESENCHYMAL STEM CELL; CELL SEPARATION; COCULTURE; CYTOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MESENCHYMAL STROMA CELL; PROCEDURES; T LYMPHOCYTE;

ANTIGENS, DIFFERENTIATION; CELL SEPARATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; HUMANS; IMMUNE TOLERANCE; MESENCHYMAL STROMAL CELLS; T-LYMPHOCYTES; UMBILICAL CORD;

EID: 84926466424     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2014.0385     Document Type: Article

References (16)

1. Gnecchi, M., and Melo, L.G. Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. Methods Mol Biol 482, 281, 2009.
2. Bieback, K., and Kluter, H. Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther 2, 310, 2007.
3. In'tAnker, P.S., Scherjon, S.A., Kleijburg-van derKeur, C., de Groot-Swings, G.M., Claas, F.H., Fibbe, W.E., and Kanhai, H.H. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22, 1338, 2004.
4. Gruber, H.E., Deepe, R., Hoelscher, G.L., Ingram, J.A., Norton, H.J., Scannell, B., Loeffler, B.J., Zinchenko, N., Hanley, E.N., and Tapp, H. Human adipose-derived mesenchymal stem cells: direction to a phenotype sharing similarities with the disc, gene expression profiling, and coculture with human annulus cells. Tissue Eng Part A 16, 2843, 2010.
5. Tong, C.K., Vellasamy, S., Tan, B.C., Abdullah, M., Vidyadaran, S., Seow, H.F., and Ramasamy, R. Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biol Int 35, 221, 2011.
6. Salehinejad, P., Alitheen, N.B., Ali, A.M., Omar, A.R., Mohit, M., Janzamin, E., Samani, F.S., Torshizi, Z., and Nematollahi-Mahani, S.N. Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly. In Vitro Cell Dev Biol Anim 48, 75, 2012.
7. Han, Y.F., Tao, R., Sun, T.J., Chai, J.K., Xu, G., and Liu, J. Optimization of human umbilical cordmesenchymal stemcell isolation and culture methods. Cytotechnology 65, 819, 2013.
8. Margossian, T., Reppel, L., Makdissy, N., Stoltz, J.F., Bensoussan, D., and Huselstein, C. Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion. Biomed Mater Eng 22, 243, 2012.
9. Ishige, I., Nagamura-Inoue, T., Honda, M.J., Harnprasopwat, R., Kido, M., Sugimoto, M., Nakauchi, H., and Tojo, A. Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. Int J Hematol 90, 261, 2009.
10. He, H., Nagamura-Inoue, T., Tsunoda, H., Yuzawa, M., Yamamoto, Y., Yorozu, P., Agata, H., and Tojo, A. Stagespecific embryonic antigen 4 in Wharton's jelly-derived mesenchymal stem cells is not a marker for proliferation and multipotency. Tissue Eng Part A 20, 1314, 2014.
11. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., and Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
12. Horwitz, E.M., Le Blanc, K., Dominici, M., Mueller, I., Slaper-Cortenbach, I., Marini, F.C., Deans, R.J., Krause, D.S., Keating, A., and International Society for Cellular, T. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7, 393, 2005.
13. Nagamura-Inoue, T., and He, H. Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. World J Stem Cells 6, 195, 2014.
14. Sarugaser, R., Lickorish, D., Baksh, D., Hosseini, M.M., and Davies, J.E. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 23, 220, 2005.
15. Prasanna, S.J., Gopalakrishnan, D., Shankar, S.R., and Vasandan, A.B. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 5, e9016, 2010.
16. Santos, J.M., Barcia, R.N., Simoes, S.I., Gaspar, M.M., Calado, S., Agua-Doce, A., Almeida, S.C., Almeida, J., Filipe, M., Teixeira, M., Martins, J.P., Graca, L., Cruz, M.E., Cruz, P., and Cruz, H. The role of human umbilical cord tissuederived mesenchymal stromal cells (UCX(R)) in the treatment of inflammatory arthritis. J Transl Med 11, 18, 2013.